The NHS faces "unprecedented" pressure as the UK reports record numbers for a second day running.
Everolimus: from April, it will no longer be available in England to treat breast cancer (Image: P. Marazzi/SPL) Changes to England’s Cancer Drugs Fund mean that from April, new cancer patients will no longer be able to receive a number of expensive treatments – including three breast cancer medicines – that have hitherto been available on the National Health Service. Established in 2011, the CDF
リリース、障害情報などのサービスのお知らせ
最新の人気エントリーの配信
処理を実行中です
j次のブックマーク
k前のブックマーク
lあとで読む
eコメント一覧を開く
oページを開く